OpenVSafe by OpenVAERS
Search V-safe

E23-95446-33794

2 vaccinations 8 coded responses 16 check-ins 8 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
212 / MD
Registered
2021-01-29
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-29
    Registered in v-safe
  2. 2021-01-29
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-29
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site
    Free text: I had this rash prior to the vaccine and it is still present. A topic dermatitis rash on eyelids and hands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dermatitis, Eyelid rash, Pre-existing disease, Rash, Rash papular — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site
    Free text: Rash above and on both eyelids and also both hands on the back of the hands. A topic dermatitis from before the injection but still present
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Eyelid rash, Rash — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Eyelid and hand rash improving with treatment
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Rashes continues to improve
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Eyelid rash, Rash — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Eyelid and hand rash stable and similar to yesterday. Still
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-05
    Survey response — day 7, dose 1
    MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Rash improving
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-19
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-26
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-03-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-21
    Survey response — 3 months, dose 2
    MedDRA: Menstruation delayed — Feeling: Good
    Free text: My period came 75 days late after second vaccine dose administration.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-08-20
    Survey response — 6 months, dose 2
    MedDRA: Menstruation delayed, Menstruation irregular — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: After my second dose of the Pfizer vaccine, I lost my period for 77 days. When it returned it did not return at its regular interval. It did not return for another 46 days. I had never had these symptoms before. My periods have always been very re
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  20. 2021-08-20
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  21. 2021-08-27

Vaccinations

DoseDateManufacturerCo-administered
12021-01-29Pfizer-BioNTech
22021-02-19Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-01-30

Systemic reaction (other): I had this rash prior to the vaccine and it is still present. A topic dermatitis rash on eyelids and hands

2021-01-31

Systemic reaction (other): Rash above and on both eyelids and also both hands on the back of the hands. A topic dermatitis from before the injection but still present

2021-02-01

Systemic reaction (other): Eyelid and hand rash improving with treatment

2021-02-02

Systemic reaction (other): Rashes continues to improve

2021-02-04

Systemic reaction (other): Eyelid and hand rash stable and similar to yesterday. Still

Release 3 — day 7, dose 1

2021-02-05

Systemic reaction (other): Rash improving

Release 8 — 3 months, dose 2

2021-05-21

Symptoms: My period came 75 days late after second vaccine dose administration.

Release 9 — 6 months, dose 2

2021-08-20

Symptoms: After my second dose of the Pfizer vaccine, I lost my period for 77 days. When it returned it did not return at its regular interval. It did not return for another 46 days. I had never had these symptoms before. My periods have always been very re

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDMenstruation delayed ✓ ✓ ✓
SDMenstruation irregular ✓ · ✓
SRODermatitis ○ ✓ ○
SROEyelid rash ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SRORash ✓ ✓ ✓
SRORash papular ○ ✓ ○

✓ active code · ○ coded but marked inactive · blank = not in that release